How should a rash associated with lithium therapy be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Rash with Lithium: Evaluation and Management

A rash associated with lithium therapy should be evaluated clinically for type and severity, managed initially with topical treatments while continuing lithium in most cases, but requires lithium discontinuation if severe, bullous, or associated with systemic symptoms suggesting DRESS syndrome.

Clinical Context and Prevalence

Cutaneous reactions to lithium are common, occurring in 38-45% of patients on lithium therapy 1, 2, 3. The FDA label warns that lithium toxicity is closely related to serum levels and can occur at therapeutic doses 4. Male patients are more susceptible to developing cutaneous reactions than females 2.

Types of Cutaneous Reactions

The most common lithium-associated skin manifestations include:

  • Acneiform eruptions (most frequent) 5, 2, 3
  • Maculopapular rash 1, 5
  • Psoriasis (new onset or exacerbation) 6, 7, 2
  • Folliculitis 2, 8
  • Alopecia 7, 3

Critical pitfall: Lithium can precipitate or severely worsen psoriasis, which may become treatment-resistant 6, 8. The psoriasis guideline specifically identifies lithium as potentially causing "severe, even life-threatening, deterioration of psoriasis" 6.

Evaluation Algorithm

1. Assess Rash Characteristics

  • Distribution and body surface area involved
  • Presence of mucosal involvement
  • Bullous or exfoliative features
  • Pruritus severity

2. Check for Systemic Features (DRESS Syndrome)

  • Fever
  • Lymphadenopathy
  • Eosinophilia with atypical lymphocytes
  • Liver dysfunction
  • Cardiac symptoms (troponin T elevation)

Critical warning: DRESS syndrome with lithium can cause life-threatening myocarditis 9. One case report documented refractory cardiac myocarditis requiring mycophenolate mofetil after lithium/quetiapine therapy 9.

3. Laboratory Assessment

  • Complete blood count (check eosinophilia)
  • Liver function tests
  • Serum lithium level
  • Troponin T if cardiac symptoms present

4. Consider Dermatology Consultation

  • For diagnostic uncertainty
  • Severe or resistant cases
  • Suspected psoriasis or DRESS syndrome

Management Strategy

Mild Reactions (Acne, Mild Folliculitis)

  • Continue lithium at current dose 5, 2
  • Topical treatments:
    • Moderate-to-high potency topical corticosteroids
    • Topical antibiotics for superinfected lesions
    • Standard acne treatments
  • Monitor for progression

Moderate Reactions (Extensive Maculopapular Rash, Moderate Psoriasis)

  • Consider dose reduction in consultation with psychiatrist 8
  • Dermatology referral for psoriasis management
  • Topical corticosteroids and disease-specific treatments
  • Continue monitoring - most cases manageable without lithium discontinuation 5, 2

Severe Reactions - DISCONTINUE LITHIUM

  • Bullous or exfoliative eruptions
  • Suspected DRESS syndrome (fever, eosinophilia, organ involvement)
  • Treatment-resistant psoriasis 6, 2
  • Mucosal involvement with systemic symptoms

Evidence from challenge-dechallenge-rechallenge: One case demonstrated clear causality - rash resolved 6 days after lithium withdrawal and recurred within 1 day of rechallenge 1.

Monitoring Recommendations

Based on bipolar disorder guidelines, baseline and follow-up monitoring should include assessment of side effects 10. For cutaneous reactions specifically:

  • Educate patients about potential skin reactions before initiating lithium 3
  • Regular skin examination during follow-up visits
  • Document any pre-existing skin conditions (especially psoriasis, lupus) 3
  • If severe reactions develop, check troponin T and consider FDG-PET/CT for myocarditis 9

Key Clinical Pearls

  1. Blood levels matter: Dermatoses may correlate with lithium blood levels 8
  2. Neutrophilic conditions worsen: Lithium exacerbates conditions with neutrophilic infiltration 2
  3. Pre-existing conditions: Severe alopecia can develop in patients with pre-existing systemic lupus erythematosus 3
  4. Adherence impact: Skin reactions, though rarely severe, significantly affect medication compliance 7, 3

When to Involve Psychiatry

Discuss lithium discontinuation or dose reduction with the treating psychiatrist, as the guidelines emphasize that most youths and adults with bipolar disorder require ongoing lithium therapy to prevent relapse 10. The decision must balance dermatologic severity against psychiatric stability, recognizing that >90% of non-compliant patients relapse 10.

References

2
Research

Cutaneous adverse effects of lithium: epidemiology and management.

American journal of clinical dermatology, 2004

5
Research

Dermatological reactions to lithium: a critical review of the literature.

Journal of clinical psychopharmacology, 1982

7
Research

[Dermatologic side effects with use of lithium].

Revista medica de Chile, 2023

8
Research

[Undesirable skin reactions to lithium].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1985

10
Guideline

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

Related Questions

Can lithium therapy cause skin rashes?
Can excessive fluid intake precipitate lithium toxicity in patients on lithium therapy?
Can I take over-the-counter (OTC) lithium supplements for therapeutic purposes?
With a lithium serum concentration of 0.8 mEq/L, is it possible to have no hair‑related side effects such as hair loss (telogen effluvium) and dandruff?
What steps should I take to prepare for my upcoming neurology appointment?
In adult patients with diabetes, how should magnesium deficiency be screened and managed, including recommended oral supplementation dosing and adjustments for renal function?
What is the likelihood that blood cultures will be negative in a patient who has completed appropriate antibiotic therapy, is afebrile, but still has an abnormal white‑blood‑cell count (leukocytosis)?
In a 38-year-old woman with heavy menstrual bleeding and ultrasound showing moderate diffuse myometrial heterogeneity suggestive of diffuse adenomyosis, what does this finding indicate and what are the recommended next steps?
Two weeks after prostate artery embolization, I am passing 5‑mm clots and experiencing intermittent hematuria (red drops or pink urine) for five days; should I seek urgent medical evaluation?
Two weeks after prostate arterial embolization, I am passing 5 mm clots and have occasional light‑pink urine; is this normal and what type of CT imaging should be performed to identify the bleeding source?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.